Intermittent low dose irradiation enhances the effectiveness of radio- and chemo-therapy for human colorectal adenocarcinoma cell line HT-29

Wang,Yang; Li,Yezhou; Yang,Li; Yin,Dexin

doi:10.3892/or.2017.5679

Intermittent low dose irradiation enhances the effectiveness of radio- and chemo-therapy for human colorectal adenocarcinoma cell line HT-29

Authors:
- Yang Wang
- Yezhou Li
- Li Yang
- Dexin Yin
View Affiliations

Affiliations: Department of Gastroenterology, FAW General Hospital, Changchun, Jilin 130011, P.R. China, Department of Vascular Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
Published online on: May 30, 2017 https://doi.org/10.3892/or.2017.5679
Pages: 591-597

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Low dose irradiation (LDIR) induces hormesis and adaptive response in organism and mammalian cell lines. Notably, LDIR generates distinct biological effects in cancer cells from normal cells, e.g., it may affect the growth of cancer cells via the activation of certain cell signaling pathway, which does not exist in normal cells. Therefore, LDIR is considered as a promising assistant method of clinical cancer therapy. In this study, we chose human colorectal adenocarcinoma cell line HT-29 as the experimental model, and investigated the differential biological effects between 250 mGy single dose LDIR and 250 mGy intermittent LDIR pretreatments in high dose irradiation (HDIR) radiotherapy and 5-fluorouracil (5-FU) based chemotherapy. Through the cell growth assays, we observed that 250 mGy intermittent LDIR pretreatment significantly increased the killing effect of both radiotherapy and chemotherapy. Western blotting results showed that intermittent LDIR pretreatment apparently activated the ATM/p53 (ataxia telangiectasia mutated, ATM) pathway in radiotherapy; it also activated ERK and p38MAPK pathways in chemotherapy. When we used chemical inhibitors to block the ATM/p53 or p38MAPK pathways, the intermittent LDIR induced cell growth inhibitions were reversed. However, blockage of ERK pathway could not affect the cell growth inhibiton in chemotherapy. Taken together, our findings evaluated the intermittent LDIR as a potential valuable method that can enhance the effectiveness of radiotherapy and chemotherapy, especially in the radio- or chemo-resistant tumor types.

View Figures

View References

1	Su XL, Wang YF, Li SJ, Zhang F and Cui HW: High methylation of the SEPT9 gene in Chinese colorectal cancer patients. Genet Mol Res. 13:2513–2520. 2014. View Article : Google Scholar : PubMed/NCBI
2	Yang XD, Xu XH, Zhang SY, Wu Y, Xing CG, Ru G, Xu HT and Cao JP: Role of miR-100 in the radioresistance of colorectal cancer cells. Am J Cancer Res. 5:545–559. 2015.PubMed/NCBI
3	Tang FR and Loke WK: Molecular mechanisms of low dose ionizing radiation-induced hormesis, adaptive responses, radioresistance, bystander effects, and genomic instability. Int J Radiat Biol. 91:13–27. 2015. View Article : Google Scholar : PubMed/NCBI
4	Guo M and Dou J: Advances and perspectives of colorectal cancer stem cell vaccine. Biomed Pharmacother. 76:107–120. 2015. View Article : Google Scholar : PubMed/NCBI
5	Luckey TD: Physiological benefits from low levels of ionizing radiation. Health Phys. 43:771–789. 1982. View Article : Google Scholar : PubMed/NCBI
6	Feinendegen LE: Evidence for beneficial low level radiation effects and radiation hormesis. Br J Radiol. 78:3–7. 2005. View Article : Google Scholar : PubMed/NCBI
7	Olivieri G, Bodycote J and Wolff S: Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science. 223:594–597. 1984. View Article : Google Scholar : PubMed/NCBI
8	Yang G, Li W, Jiang H, Liang X, Zhao Y, Yu D, Zhou L, Wang G, Tian H, Han F, et al: Low-dose radiation may be a novel approach to enhance the effectiveness of cancer therapeutics. Int J Cancer. 139:2157–2168. 2016. View Article : Google Scholar : PubMed/NCBI
9	Liang X, Gu J, Yu D, Wang G, Zhou L, Zhang X, Zhao Y, Chen X, Zheng S, Liu Q, et al: Low-dose radiation induces cell proliferation in human embryonic lung fibroblasts but not in lung cancer cells: Importance of ERK1/2 and AKT signaling pathways. Dose Response. 14:15593258156221742016. View Article : Google Scholar : PubMed/NCBI
10	Shin YK, Yoo BC, Hong YS, Chang HJ, Jung KH, Jeong SY and Park JG: Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis. 30:2182–2192. 2009. View Article : Google Scholar : PubMed/NCBI
11	Hafner MF and Debus J: Radiotherapy for colorectal cancer: Current standards and future perspectives. Visc Med. 32:172–177. 2016. View Article : Google Scholar : PubMed/NCBI
12	Longley DB, Harkin DP and Johnston PG: 5-fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer. 3:330–338. 2003. View Article : Google Scholar : PubMed/NCBI
13	Grem JL: 5-Fluorouracil: Forty-plus and still ticking. A review of its preclinical and clinical development. Invest New Drugs. 18:299–313. 2000. View Article : Google Scholar : PubMed/NCBI
14	Sui X, Kong N, Wang X, Fang Y, Hu X, Xu Y, Chen W, Wang K, Li D, Jin W, et al: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy. Sci Rep. 4:46942014. View Article : Google Scholar : PubMed/NCBI
15	Violette S, Poulain L, Dussaulx E, Pepin D, Faussat AM, Chambaz J, Lacorte JM, Staedel C and Lesuffleur T: Resistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status. Int J Cancer. 98:498–504. 2002. View Article : Google Scholar : PubMed/NCBI
16	Wei MF, Chen MW, Chen KC, Lou PJ, Lin SY, Hung SC, Hsiao M, Yao CJ and Shieh MJ: Autophagy promotes resistance to photodynamic therapy-induced apoptosis selectively in colorectal cancer stem-like cells. Autophagy. 10:1179–1192. 2014. View Article : Google Scholar : PubMed/NCBI
17	de la Cruz-Morcillo MA, Valero ML, Callejas-Valera JL, Arias-González L, Melgar-Rojas P, Galán-Moya EM, García-Gil E, García-Cano J and Sánchez-Prieto R: P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: Implication in resistance. Oncogene. 31:1073–1085. 2012. View Article : Google Scholar : PubMed/NCBI
18	Yang G, Yu D, Li W, Zhao Y, Wen X, Liang X, Zhang X, Zhou L, Hu J, Niu C, et al: Distinct biological effects of low-dose radiation on normal and cancerous human lung cells are mediated by ATM signaling. Oncotarget. 7:71856–71872. 2016.PubMed/NCBI
19	Brazina J, Svadlenka J, Macurek L, Andera L, Hodny Z, Bartek J and Hanzlikova H: DNA damage-induced regulatory interplay between DAXX, p53, ATM kinase and Wip1 phosphatase. Cell Cycle. 14:375–387. 2015. View Article : Google Scholar : PubMed/NCBI
20	Lin K, Adamson J, Johnson GG, Carter A, Oates M, Wade R, Richards S, Gonzalez D, Matutes E, Dearden C, et al: Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: Blockade at the level of p21 is associated with short response duration. Clin Cancer Res. 18:4191–4200. 2012. View Article : Google Scholar : PubMed/NCBI